CDS Connect: Endocrinology: Hypoglycemia Rule

Endocrinology: Hypoglycemia Rule

Description

The intent of the “Hypoglycemia Rule” is to facilitate next steps in response to occurrence of a hypoglycemic event, or presence of risk factors for hypoglycemia. Actions may include activating a documentation template and order set, facilitating messages to multiple members of the care team.

Creation Date
Version
1.0
Unique Identifier
47229c7e-522c-59c6-ab26-f8ddc2809e29
Status
Experimental
True

Artifact Creation and Usage

Contributors

Leonard Pogach, MD, National Director MedicineVACO, 810 Vermont Ave. NW, Room 662 Washington, DC 20420

Paul Conlin, MD, Endocrinologist; Chief of Medicine, Boston VAMC; Chair of the Field Advisory Committee for Diabetes/Endocrinology, 1400 VFW Parkway, Boston, MA 02132

Please contact Mr. Apurva Desai Apurva.desai@va.gov for additional information.

License
IP Attestation The author asserts that this artifact has been developed in compliance with the intellectual property rights attributed to the source material.
Copyrights

Copyright © 2018 Veterans Health Administration, Department of Veterans Affairs. All rights reserved. Contributions from external parties are property of respective copyright holders.

Implementation Details
Technical Files
ECA Rule7.82 KB
Repository Information
Approval Date
Publication Date
Last Review Date
Knowledge Level

Structured code that is interpretable by a computer (includes data elements, value sets, logic)

Purpose and Usage
Usage

 

Target User
Clinical Providers caring for adult patients
Patient Age Group
Adult
Clinical Focus
Adult outpatient with an active problem of either diabetes mellitus, type 1 or type 2
Clinical Venue
Outpatient
Clinical Venue
Emergency Department (ED)
Clinical Venue
Inpatient hospital
Clinical Venue
Urgent care
Workflow Task
Care and Management of the Diabetic Patient

 

Cautions

THE CLINICAL CONTENT IN THIS DOCUMENT IS NOT DIRECTLY SUITABLE FOR CLINICAL USE AS PRESENTED SINCE IT HAS NOT BEEN TESTED IN A CLINICAL ENVIRONMENT. IT HAS NEVER BEEN PILOTED, NEVER 100% REPRESENTS THE INTENT OF THE CLINICAL SUBJECT MATTER EXPERTS, AND MAY CAUSE HARM IF APPLIED AS-IS. THIS WORK IS MADE AVAILABLE WITHOUT ANY WARRANTY WHATSOEVER, AND WITHOUT CLAIMS, EXPRESSED OR IMPLIED, OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.

Supporting Evidence
Source Description

 

See attached resource files for additional details. Department of Veterans Affairs, Veterans Health Administration, Office of Informatics and Information Governance, Clinical Decision Support (CDS) Content and Health Level 7 (HL7)-Compliant Knowledge Artifacts (KNARTs) Eye Care Clinical Content White Paper, VA118-16-D-1008, Task Order VA-118-16-F-1008-0007, June, 2018.

American Diabetes Association. Diabetes Care. Standards of medical care in diabetes-20172017;40(suppl 1):S1-S135
http://care.diabetesjournals.org/content/diacare/suppl/2016/12/15/40.Supplement_1.DC1/DC_40_S1_final.pdf
O'Neil G. V1-High Risk for Hypoglycemia. June 4, 2015 VISN 1 hypoglycemia reminder PowerPoint (Linda Wedemeyer, MD, email communication, July 10, 2017)
V1_HIGH RISK FOR HYPOGLYCEMIA.PowerPoint.ppt.
Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384-1395
https://doi.org/10.2337/dc12-2480
U.S. National Libray of Medicine. GLIPIZIDE- glipizide tablet (Actavis Pharma, Inc.). DailyMed Website. Revised June 2015
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad55dfd7-ffb5-478a-aa84-1009fa921e22
U.S. National Library of Medicine. GLUCAGON- glucagon [Eli Lilly and Company]. DailyMed Website. Revised May 2017
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f143db10-e889-41c3-84ed-603a0ab02f61
U.S. National Library of Medicine. LANTUS- insulin glargine injection, solution, LANTUS SOLOSTAR- insulin glargine injection, solution [sanofi-aventis U.S. LLC]. DailyMed WebsiteRevised August 2015
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5e07a0c-7e14-4756-9152-9fea485d654a
U.S. National Library of Medicine. LEVEMIR- insulin detemir injection, solution [Novo Nordisk]. DailyMed Website Revised February 2015
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d38d65c1-25bf-401d-9c7e-a2c3222da8af
U.S. National Library of Medicine. NOVOLOG- insulin aspart injection, solution [Novo Nordisk]. DailyMed Website. Revised March 2017
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a1e73a2-3009-40d0-876c-b4cb2be56fc5
U.S. Department of Veterans Affairs and U.S. Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Type 2 Diabetes Mellitus in Primary Care, version 5.0—2017. VA/DoD Clinical Practice Guidelines website
https://www.healthquality.va.gov/guidelines/CD/diabetes/VADoDDMCPGFinal508.pdf

 

References

 

See attached resource files for additional details. Department of Veterans Affairs, Veterans Health Administration, Office of Informatics and Information Governance, Clinical Decision Support (CDS) Content and Health Level 7 (HL7)-Compliant Knowledge Artifacts (KNARTs) Eye Care Clinical Content White Paper, VA118-16-D-1008, Task Order VA-118-16-F-1008-0007, June, 2018.

American Diabetes Association. Diabetes Care. Standards of medical care in diabetes-20172017;40(suppl 1):S1-S135
http://care.diabetesjournals.org/content/diacare/suppl/2016/12/15/40.Supplement_1.DC1/DC_40_S1_final.pdf
O'Neil G. V1-High Risk for Hypoglycemia. June 4, 2015 VISN 1 hypoglycemia reminder PowerPoint (Linda Wedemeyer, MD, email communication, July 10, 2017)
V1_HIGH RISK FOR HYPOGLYCEMIA.PowerPoint.ppt.
Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384-1395
https://doi.org/10.2337/dc12-2480
U.S. National Libray of Medicine. GLIPIZIDE- glipizide tablet (Actavis Pharma, Inc.). DailyMed Website. Revised June 2015
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad55dfd7-ffb5-478a-aa84-1009fa921e22
U.S. National Library of Medicine. GLUCAGON- glucagon [Eli Lilly and Company]. DailyMed Website. Revised May 2017
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f143db10-e889-41c3-84ed-603a0ab02f61
U.S. National Library of Medicine. LANTUS- insulin glargine injection, solution, LANTUS SOLOSTAR- insulin glargine injection, solution [sanofi-aventis U.S. LLC]. DailyMed WebsiteRevised August 2015
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5e07a0c-7e14-4756-9152-9fea485d654a
U.S. National Library of Medicine. LEVEMIR- insulin detemir injection, solution [Novo Nordisk]. DailyMed Website Revised February 2015
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d38d65c1-25bf-401d-9c7e-a2c3222da8af
U.S. National Library of Medicine. NOVOLOG- insulin aspart injection, solution [Novo Nordisk]. DailyMed Website. Revised March 2017
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a1e73a2-3009-40d0-876c-b4cb2be56fc5
U.S. Department of Veterans Affairs and U.S. Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Type 2 Diabetes Mellitus in Primary Care, version 5.0—2017. VA/DoD Clinical Practice Guidelines website
https://www.healthquality.va.gov/guidelines/CD/diabetes/VADoDDMCPGFinal508.pdf

 

Artifact Representation
Testing Experience
Pilot Experience

None